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Abstract 
Hemerythrin-like protein Rv2633c is a small 18 kDa protein that is expressed in 
Mycobacterium tuberculosis (Mtb). Sequence analysis of Rv2633c predicts the presence of a 
hemerythrin-like domain, which binds dioxygen using a µ-oxo-bridge (Fe-O-Fe), rather than a 
heme group. Though it is noticeably upregulated during macrophage infection and during in vitro 
acidification, the role of Rv2633c in Mtb survival has yet to be elucidated. This project aims to 
characterize the function of Rv2633c by studying the in vitro response of the recombinant 
protein to conditions present in the macrophage lysosome, such as reduced oxygen levels or the 
presence of reactive oxygen species. UV-visible spectroscopy is used to observe these changes, 
as the spectrum shows a characteristic peak at 330 nm that likely corresponds to the diiron 
cofactor in its native state. Our results show this spectrum shifts in response to hydrogen 
peroxide addition, showing the proposed environmental conditions can affect the active site. 
Bioinformatics techniques, such as the 3D modeling program SWISS-MODEL, have been used 
to hypothesize possible structure and function. Determining the function of Rv2633c may help 
explain how Mtb so readily evades the human immune system to reside in the macrophage.  
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INTRODUCTION 
Rv2633c 
Rv2633c is a small 18 kDa protein highly expressed by Mycobacterium tuberculosis 
(Mtb) when taken into the lysosomal compartments of the human macrophage. Microarray data 
by Dr. Kyle Rohde shows Rv2633c upregulated during TB infection of the macrophage and 
during in vitro acidification to pH 5.5-6.5 [1]. Dr. Rohde and his team have also noted the 
possible importance of the regulators WhiB3, PhoPR, and TrcRS to the expression of Rv2633c.  
An interesting feature of Rv2633c is a hemerythrin-like domain. This domain is known to 
bind oxygen using a diiron center. This domain is found in a wide range of organisms and have 
been shown to have functions such as oxygen binding, iron sequestration, and chemotaxis. Many 
of the known functions of hemerythrin-like proteins could be relevant to the environmental 
conditions within the hostile environment of the host macrophage.    
Mycobacterium tuberculosis 
In just the past 200 years, Mtb  has claimed the lives of around one billion people [2]. 
Currently, approximately 1/3 of the world’s population is infected with latent Mtb, which can 
cause tuberculosis disease if the infected person’s immune system becomes compromised [3]. 
The World Health Organization reported that in 2013, 9 million people developed tuberculosis 
(480,000 of these cases being multidrug resistant TB) while 1.5 million people died from 
tuberculosis [4]. Though great progress has been made towards treatment of tuberculosis, more 
progress must still be made in developing more effective treatments to stop the spread of this 
epidemic.  
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When Mtb enters the lungs through aerosol droplets, macrophages take in the foreign 
bacteria through phagocytosis [5]. Throughout its coevolution with the human species, Mtb has 
developed ways to survive the hostile environment of the phagolysosome by preventing its 
maturation [6]. Due to Mtb’s complex cell surface structure it can be taken up by multiple 
macrophage receptors [7]. The receptor that Mtb is taken up by can greatly affect the bacteria’s 
survival, for instance, the uptake of Mtb by the CR3 receptor prevents the activation of the 
macrophage and increases the bacteria’s chance of survival within the macrophage [8]. One 
method of preventing phagosome lysosome fusion used by Mtb is blocking the accumulation of 
the membrane component phosphatidylinositol 3-phosphate (PI3P) onto the phagosome [9, 10]. 
This component is thought to bind several proteins involved in the fusion of the phagosome and 
lysosome [11]. 
Mtb Survival in the Host 
Mtb can also remain alive within the macrophage phagolysosome even as the pH 
becomes acidic, usually between pH 5.0 and 4.5 [12]. Mtb has also been shown to multiply even 
when inside the phagolysosome [6]. Mycobacterium species have even been found surviving in 
the volcanic springs of Yosemite National park at pH as low as 1 [13]. An analysis of the rRNA 
content of highly acidic endolithic environments of Yellowstone national park showed that 37% 
of species were Mycobacterium [13]. Some species of bacteria such as Listeria monocytogenes 
even require the acidity of the lysosome for survival or for the activation of virulence factors 
[14].  There are many possible methods used by Mtb to maintain pH homeostasis in acidic 
conditions. Mtb most likely uses some of the common methods used by most bacteria, such as 
cation pumps to regulate internal pH, or a urease to produce ammonia [15-17]. The tough cell 
wall of Mtb is also a likely defense against acidic environments. The bacteria’s cell wall has a 
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bilayer membrane incased by a peptidoglycan layer that is covalently bonded to long mycolic 
acids [18].  
Mtb, like essentially all other organisms, requires iron for growth, and free iron a limiting 
nutrient in the host. Most (70-75%) of iron in the human body is bound to the porphyrin, which 
eventually forms heme [19]. The remaining iron not bound to heme is bound to the proteins 
transferrin, lactoferrin, or ferritin [20].  Mycobacterium tuberculosis is known to sequester iron 
using compounds called siderophores, which is a type of compound that strongly binds Fe3+ [21]. 
Mtb has two main siderophores: mycobactin T and carboxymycobactin [22]. Mycobactin binds 
iron intracellularly while carboxymycobactin binds iron extracellularly [23]. Carboxymycobactin 
can remove the iron from both ferritin and transferrin [24]. Rv1436, or glycolytic enzyme 
glyceraldehyde-3-phosphate dehydrogenase, exists on the cell surface of Mtb and directly binds 
human transferrin and internalizes it, without the need for siderophores [25].  
All aerobic organisms must have defenses used to scavenge reactive oxygen species, such 
as superoxide and hydrogen peroxide [26] [27]. The damaging effects of reactive oxygen species 
have been utilized by many organisms as a defense against pathogens [28]. Mtb has many known 
strategies to combat these reactive oxygen species. The bacteria uses the enzymes catalase and 
superoxide dismutase, as well as peroxiredoxins to defend against the reactive environment of 
the host macrophage [29] [30]. A unique method used by mycobacteria is the use of mycothiol, 
which is a thiol present within the cytoplasm that create a reducing environment that helps 
defend against hydrogen peroxide [31]. 
M. tuberculosis and other related species of mycobacterium such as M. leprae can inhibit 
the fusing of the phagosome with the lysosome [32], and therefore can remain in an environment 
more suitable to survival at a more mild pH of around 6.2 [12].  After initial entry into the 
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phagosome, the phagosome buds off from the membrane and forms smaller vacuoles that cannot 
fuse with lysosomes, protecting the bacteria [33]. Although much is known about bacterial 
survival in the macrophage, many questions remain. 
The genes whiB3 and phoPR, have been shown to be upregulated in response to low pH, 
while trcR is upregulated during the initial stages of Mtb infection in humans [34-36]. WhiB is a 
gene family of seven genes (whiB1-7) that express transcription factors under varying conditions 
of environmental stress to mycobacterium [37]. WhiB3 is expressed 12 fold higher when the cell 
is introduced to the low pH similar to the phagosome environment [38]. PhoPR is a two 
component regulatory system that is involved in virulence and lipid synthesis for the cell 
envelope [39].  Strains of Mtb that have an inactivated phoPR gene show considerably 
diminished ability to grow within macrophage like cells [39]. The phoPR regulatory system also 
appears to sense pH, as it modulates expression of several environmental pH dependent genes 
[40]. TrcR is a regulator that binds and inhibits Rv1057 in Mtb, which is a protein that has a 
beta-propeller fold structure and is involved in early growth within the human macrophage [41]. 
Little is known about its structure or function. Preliminary evidence suggests these 
transcriptional regulators each play a role in the regulation of the gene encoding Rv2633c 
(Preliminary data, Rohde).  
Hemerythrin  
Hemerythrins are metalloproteins that reversibly bind dioxygen using two iron atoms 
[42]. Unlike most other dioxygen binding proteins hemerythrin contains no heme cofactor. The 
molecular weight of the hemerythrin octamer of the worm species Pectinaria gouldii is 107,000, 
and the subunits have molecular weights of 13,500, and most other hemerythrins have similar 
molecular weights [43]. They are most often found in various types of marine invertebrates. The 
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hemerythrins of the peanut worm, Sipunculida, have been the most extensively studied of this 
group [44]. The hemerytherin proteins are usually octomeric in the blood and monomeric when 
in the muscle cells [45]. The monomer is referred to as myohemerythrin. Other oligomers 
including dimeric, trimeric, and tetrameric has also been found [42]. It is thought the 
hemerythrins and myohemerythrins play the role in these invertebrates that hemoglobin and 
myoglobin play in other species [44].  
Myohemerythrin has four approximately parallel alpha helices that surround the two iron 
atoms [46].The binding site within the channel created by the parallel alpha helices contain 
hydrophobic amino acid residues that likely serve to create a binding environment for O2  [42]. 
The N terminal has a disordered, nonhelical region [46]. The protein connects to the iron atoms 
at 6 residues, with 3 residues to each iron atom. A residue from each of the 4 alpha helices 
coordinates in a perpendicular plane with the iron atoms [46]. Access to the diiron center is 
obstructed by the N-terminal arm and a side chain of one of the helices [46].  
The diiron core in the active site of hemerythrin proteins from marine invertebrates are 
connected by a µ-oxo-bridge (Fe-O-Fe) and two carboxylate groups from corresponding 
aspartate and glutamate residues [47]. Three histidine residues coordinate with Fe1 and two 
histidine residues and a glutamate residue coordinate Fe2 [48]. The diiron center can usually be 
found in the deoxy, met, or oxy state. The µ-oxo bridge is retained in each oxidation state [49]. 
When in the deoxy form, the oxidation states are Fe (II, II), but they transition to Fe (III, III) in 
the oxy state [50]. In the deoxy state the bridging oxygen is protonated [49]. The proposed 
mechanism for O2 binding is the proton from the bridging oxygen is transferred to O2 to stabilize 
bound to Fe in the peroxy state [49]. When the Fe-O-Fe center is not bound to oxygen in the 
deoxy state, the Fe-O distances are 1.8 Å and the Fe-Fe distance is 3.57 Å. When O2 is bound the 
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Fe-O distances are 2.0 Å and the Fe-Fe distance is 3.24 Å [49]. The dioxygen is bound in a 
hydroperoxy state, rather than a dioxygen complex which is quite different from usual dioxygen 
binding molecules. Hemerythrin can also bind to other ligands similar to O2 such as nitric oxide, 
or azide [42].  
Hemerythrins were first found in certain species of marine invertebrates; Sipuncula 
(peanut worm), Priapulida, Brachiopoda, and several different annelids [51, 52]. Similar 
proteins have been found scattered throughout bacterial species and have even been found in 
archaea. This leads some to believe that hemerythrin may be a protein that was acquired 
horizontally in bacteria and archaea [44].  
An evolutionary biology study published by Xavier Bailly and his team in 2008 searched 
for the hemerythrin domain throughout hundreds of different genomes within eukaryotes, 
archaea, and, bacteria. Along with the already known marine invertebrates, 13 species of fungi 
were found to contain hemerythrin, though they differed substantially in sequence when 
compared to the original motif [53].  43 archaeal species were studied, and only 4 species 
contained the hemerythrin motif [53]. 444 bacterial genomes were analyzed, and 118 different 
species contained the hemerythrin motif [53]. 242 of the proteins were single domain and 84 
were domains on chimeric proteins [53]. Of these chimeric proteins, 32 were domains of 
chemotaxis proteins. It should be noted that oxygen requirements of the bacterial species had no 
correlation to the presence of hemerythrin [53].  
Many of the sequences found to align with hemerythrin were altered slightly at important 
residues. The most common differences were changes in one of the 4 alpha helices or a 
substitution in one of the five histidine residues which coordinate the two iron atoms. The most 
common of these substitutions was a glutamine replacing the histidine [53].  
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The hemerythrin protein motif was shown to be sporadically present throughout all 
domains of life, but is obviously overshadowed by hemoglobin, especially in highly evolved, 
multicellular organisms. The same study suggests that hemerythrin may have lost evolutionary 
favor due to its greater potential for damaging mutations, as it needs seven different residues 
placed correctly in order to bind the iron atoms.  
Hemerythrin-like Domains in Biology 
It has become apparent that hemerythrin-like domains have been adapted for a broad 
range of functions in an even broader range of organisms. The first hemerythrin protein studied 
in bacteria was McHr, a hemerythrin protein from Methylococcus capsulatus [54]. It is predicted 
as an O2 transporter to deliver oxygen to particulate methane monooxygenase (pMMO) for 
methane oxidation [54].  Desulfovibrio vulgaris is an anaerobic bacterium uses a hemerythrin-
like domain as a chemotaxis protein. The hemerythrin-like domain senses the presence of O2, 
which triggers a cascade that alters the swimming behavior of the cell away from oxygen [55]. 
The ovohemerythrin protein YP14 is hypothesized to serve as an iron storage protein during the 
development of Theromyzon tessulatum, a species of leech [56]. A hemerythrin-like protein 
found in Mycobacterium smegmatis, msmHr, has recently been shown to regulate the expression 
of the sigma factor SigF in response to hydrogen peroxide rich environments. It appears to down 
regulate the production of SigF when hydrogen peroxide is not present, as over expressed 
msmHr downregulated the expression of SigF and caused increased susceptibility to oxidative 
stress [57].  
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MATERIALS AND METHODS 
Sequence Analysis 
 NCBI Basic Local Alignment Search Tool (BLAST) sequencing was used to compare 
the hemerytherin-like domain in Rv2633c to conserved sequences in order to predict its structure 
and function [58]. NCBI COBALT was used to create a multiple sequence alignment of proteins 
with sequences most related to Rv2633c. ExPASy ProtParam peptide properties calculator was 
used to analyze the amino acid content of the wild type protein.  
Protein Structure Analysis 
The secondary structure prediction program CFSSP (Chou & Fasman Secondary 
Structure Prediction Server) was used to analyze the possible secondary structure of Rv2633c 
[59, 60]. The SWISS-MODEL program was used to determine a probable structure of the protein 
and active site based on similarly conserved protein structures [61, 62]. The program MODFold 
4 was used to independently access the probability of the constructed models fitting the native 
structure of the protein [63-65]. The program COFACTOR was used to determine the possible 
ligand binding sites of the generated protein models [66-68]. These results were used to 
determine possible mutagenesis sites to target for further studies. 
Expression Protocols 
 Rv2633c was expressed in BL21(DE3) E. coli using the well described T7 promoter 
expression system [69]. The expression time and temperature varied, and was either overnight at 
room temperature or 3 hours at 37ºC. The pET100 expression vector used for each purification 
produces a tagged protein that includes an N-terminal histidine tag for protein purification. The 
gene is only expressed in E. coli strains that contain the T7 polymerase gene, such as derivatives 
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of strain BL21(DE3), under control of the lac promoter/operator region the lambda attachment 
region. Large scale expression was undertaken after small scale expressions of around 100ml to 
1 L showed sufficient soluble protein for purification. The cells were lysed by French press in 50 
mM tris pH 8.0 with 10 mM lysis solution buffer and the supernatant was obtained by 
ultracentrifugation for 10 minutes at 40,000 x g. 
 Purification of Rv2633c  
A cobalt affinity column was used for affinity purification. The column (approximately 
10 ml) was run using a low pressure peristaltic pump and using a 50 mM Tris buffer (pH 8.0). 
After initial application of the sample to the column, it was washed with 10 column volumes of 
buffer. 25 mM imidazole (in tris buffer) in 50 mM tris buffer pH 8.0 was used to elute the 
recombinant protein from the column. In separate purification procedures, 25 mM EDTA was 
added to the column, rather than imidazole, to strip the cobalt from the column, and therefore the 
bound recombinant protein, from the column. This was done to avoid using imidazole, which 
evidence suggests may strip the cofactor out of the protein. Following elution, the protein was 
dialyzed with 3.5 kDa dialysis tubing overnight at 4ºC in  3 liters 50 mM Tris buffer pH 8.0, to 
remove the imidazole and EDTA, respectively. The purified protein from each expression and 
purification was aliquoted into 0.5 ml samples and frozen at -80ºC.  
Protein Quantification 
SDS-PAGE was used as a qualitative method to determine the purity of Rv2633c. The 
purified protein was quantified using the guanidine hydrochloride method. This was done with 6 
M guanidine HCl in 0.05 M tris pH 8.0. The correlated extinction coefficient will be determined 
by Protparam, a protein sequence analysis online tool. The absorbance at 280 nm was measured 
using UV spectrophotometry to determine the concentration of various protein volumes. 
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Quantitative Bradford assay was also used to determine the relative amount of protein for each 
expression and purification of Rv2633c.  
Oxygen Binding Experiments  
A one ml anaerobic quartz cuvette containing the purified Rv2633c was used to study the 
protein’s response to anaerobic conditions. Nitrogen was sparged into the cuvette for 30 minutes. 
Oxygen was added back into the anaerobic protein in 50 µl intervals to determine the protein’s 
ability to bind oxygen. Spectrophotometry was used to observe possible spectral changes 
between anaerobic and aerobic conditions.  
Nitric Oxide Binding Experiments  
In order to further study the possible binding of Rv2633c, SNAP (S-Nitroso-N-
acetylpenicillamine) was added to produce nitric oxide, which often binds to metal containing 
cofactors also known to bind oxygen. 0.1 mM SNAP in 90% ethyl alcohol was added to 1 ml of 
recombinant Rv2633c. After 10 minutes of no noticeable activity the molarity of SNAP was 
increased to 1 mM. UV-visible absorbance spectrometry was used to measure changes in 
absorbance of the protein.  
Hydrogen Peroxide Experiments 
 Hydrogen peroxide was added to the protein in varying concentrations and changes in 
spectrum were measured with UV visible spectrophotometry. Various concentrations of 
hydrogen peroxide were used to determine the true reactivity of Rv2633c with reactive oxygen 
species.  
To observe the reaction of Rv2633c under high concentrations of hydrogen peroxide, 50 
µl of 3% hydrogen peroxide was added to 950 µl of  3.2 mg/ml Rv2633c (concentration 
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determined by guanidine denaturation). Measurements of UV-visible absorbance were taken at 
minute scale time points up to 45 minutes to observe the complete changes in spectrum. BSA as 
well as water were used to repeat the experiment with the same volumes and concentrations to 
serve as negative controls. After the reaction came to completion, Rv2633c was dialyzed in 3.5 
kDa dialysis tubing in 1.5 liters of 50 mM tris pH 8.0 overnight at 4º and then reexamined by 
UV-visible spectrometry to test for reversibility of the reaction.  
To measure kinetic changes in absorbance produced by hydrogen peroxide addition, the 
same concentrations and volumes of hydrogen peroxide and protein were used as above. UV-
visible absorbance spectrum measurements were taken every 15 seconds for 3 minutes. The 
experiment was repeated with matching concentrations using water and BSA as controls.  
Redox State Experiments 
The reducing agents glutathione and TCEP (tris(2-carboxyethyl)phosphine) were used to 
study the effects of reducing conditions on Rv2633c. 0.1 mM of both TCEP and glutathione was 
added to 1 ml of protein, and increased to 1 mM and then 10 mM after 10 minutes with no 
noticeable reaction. The UV-visible absorbance spectrum was measured in order to measure the 
response of the protein to the reducing agents. After the addition of 10 mM reducing agent, the 
protein was dialyzed with 3.5 kDa dialysis tubing overnight at 4ºC in 50 mM tris buffer pH 8.0, 
in order to determine whether or not results were reversible upon removal of the reducing agents. 
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RESULTS 
Protein Structure Prediction and Modeling 
Sequence Analysis  
NCBI BLAST Protein alignments of Rv2633c excluding Mtb returns mainly highly 
similar sequences of hypothetical proteins in other closely related mycobacterium species. NCBI 
BLAST protein search excluding all mycobacterium species predicts the most similar sequence 
identity as 44%. The majority of similar sequences are hypothetical proteins with hemerythrin 
and hemerythrin-like domains, with no known structure or function. Sequence analysis of 
Rv2633c clearly demonstrates the unique nature of this protein. While the unique nature of 
Rv2633c makes it an exciting candidate for further study, it also creates challenges in 
understanding of the protein structure and its function in Mtb.  
NCBI BLAST of the full sequence of Rv2633c matches with high probability for a 
hemerythrin HHE cation binding domain, as well as the hemerythrin-like superfamily. This 
domain is identified for residues 2-116 and 5-115, respectively. However, other interesting 
information was obtained by analysis of smaller portions of the full sequence. BLAST sequence 
analysis followed by generation of a phylogenic tree based on the multiple alignment shows a 
homology match with the ferritin-like superfamily domain. This protein superfamily is 
characterized by the ability to catalyze dioxygen-dependent oxidation-hydroxylation using a 
diiron center [70]. However, the ferritin like superfamily has a 4 alpha helix protein structure, 
and the 45 amino acid sequence matched is likely only a portion of this domain.  
COBALT was used to generate a protein sequence alignment of related species of 
mycobacteria using the full sequence of Rv2633c, as well as smaller portions located at the C-
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terminus that seemed more isolated to mycobacterium. This program was also used to analyze 
the sequence similarities of the proteins used as templates for structural predictions of Rv2633c.  
Analysis of related mycobacterium species by sequence similarity and predicted 
phylogeny showed that sequence similarity correlated with the degree of pathogenicity of the 
mycobacterium species. Mycobacterium species that are well established pathogens were more 
closely related than those that are considered to be opportunistic pathogens in the host (figure 2). 
The full protein sequence was analyzed as well as two different lengths of the C-terminus, as this 
region of the protein sequence is more unique to mycobacterium. BLAST sequence analysis 
returns only one mycobacterium species known to be nonpathogenic as a significant alignment, 
Mycobacterium indicus pranii (figure 2). This nonpathogenic species of mycobacterium had the 
least sequence similarity when compared to Rv2633c from Mycobacterium tuberculosis at a 
sequence identity of 56%. BLAST sequencing and phylogeny using COBALT alignment shows 
only opportunistic and fully pathogenic mycobacteria have sequence homology to the 45 amino 
acids at the carboxyl terminus that do not correspond to the predicted hemerythrin domain, the 
region in which a ferritin-like domain exists (figure 3). The same process was repeated with just 
the last 23 amino acids on the carboxyl terminus, as portion of the sequence could not be 
matched with any structurally homologous models when generating hypothetical 3D structural 
models (figure 4). This small portion of the sequence further narrows down the range of related 
mycobacterium species. A small subset of opportunistic and fully pathogenic mycobacterium 
species were shown as homologues to this portion of Rv2633c. The figures below show a 
sequence alignment of all conserved mycobacterium species generated from the NCBI databases, 
each phylogenetic tree was generated from this alignment. Phylogenetic trees generated from the 
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blast results show the evolutionary distances predicted from mycobacterium species with 
conserved protein sequences.  
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Figure 1: Sequence Alignment of Rv2633c with Related Mycobacteria Species 
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Figure 2: Phylogenic tree of full protein sequence  
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Figure 3: Phylogenic Tree of Rv2633c with homologs based on comparisons using amino acid sequence 116-161 
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Figure 4 : Phylogenic Tree of Rv2633c with homologs based on comparisons using amino acid sequence 138-161 
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Predicted Secondary Structure 
CFSSP generated a prediction of the secondary structure of Rv2633c. Figure 5 shows the 
most likely secondary structure of the protein sequence [59, 60]. The table shows the amino acid 
residues by sequence, with H, E, T, and C corresponding to the secondary structures helix, beta 
strand, turn, and coil, respectively [59, 60]. The most prevalent secondary structure predicted 
from this program was alpha helical. Figure 5 shows the presence of alpha helices scattered 
throughout, with the largest between residues 125 and 140. Some small areas predict the 
presence of beta sheets. Coils and turns are also predicted to be 9.9% of the protein residue 
structure. These areas likely correspond to areas with more flexible structure.  
Figure 5: Predicted Secondary Structure  
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3D Structural Modeling  
SWISS-MODEL was used create probable 3D structures of Rv2633c based on 
preexisting structural models of homologous proteins taken from the Protein Data Bank. Four 
models were produced using the homologous protein structures as templates. The selected 
models were Hypothetical protein NMB1532, F-box/LRR-repeat protein 5, hemerythrin-like 
domain protein DcrH, and bacteriohemerythrin from Methylococcus capsulatus. These selections 
were made based on predictions made by the SWISS-MODEL program on the degree of 
structural and sequence similarity. Figure 6 shows an alignment of the four selected protein 
templates compared to Rv2633c, in the order Rv2633c, NMB1532, Hemerythrin-like domain 
protein, FBXL5, and Methylococcus capsulatus bacteriohemerythrin. The sequences are highly 
varied, with the only similar alignments being related to the hemerythrin domain portion. The 
table 1 shows relevant features of the matched templates. These four protein templates were 
selected for further study based on their sequence identity, template coverage of Rv2633c, and 
the presence of relevant ligands. The alignment of each structural template used to generate 3D 
structural predictions shows how different each sequence, the only similarity is the hemerythrin-
like domain. 
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Figure 6: CLUSTAL Multiple Sequence Alignment of Structural Template Sequences 
 
Table 1: Structural Templates  
Template Name Sequence 
Similarity 
% 
Sequence 
Identity 
Ligands Organism 
Hypothetical protein 
NMB1532 
0.30 18.38 2 Mn2+ Neisseria 
meningitidis 
hemerythrin-like domain 
protein DcrH 
0.27 15.93 µ-oxo-diiron Desulfovibrio 
vulgaris 
Bacteriohemerythrin 
Leu144F mutant from 
Methylococcus capsulatus 
0.28 15.32 Fe2+ Methylococcus 
capsulatus 
F-box/LRR-repeat 
protein 5 
0.30 20 µ-oxo-diiron Human 
  
The model generated from Hypothetical protein NMB1532 was rated the most accurate 
by the SWISS-MODEL program, and also had the greatest amount of amino acid residue 
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coverage when modeled from the template to Rv2633c. This template was able to model residues 
1-138 of Rv2633c. 
Though the templates used were rated to be the most similar to Rv2633c, they still had 
relatively low homology, showing once again the unique sequence of Rv2633c. SWISS-MODEL 
estimates that a sequence similarity of .5 or over generates a structural model highly similar to 
the native form. No template was available to model the last 22 amino acid residues on the 
carboxyl end. This unique portion of this structure may serve a function more unique to Mtb. 
Secondary structure predictions of this unique carboxyl portion suggest an unstructured region, 
possibly a beta strand, followed by a small alpha helix. Structural modeling of this portion was 
done using SWISS-MODEL with a protein template from pyruvoyl-dependent arginine 
decarboxylase. This smaller independent molecule extends the modeled section by 11 amino acid 
residues and also predicts a beta strand. The 11 amino acid residues remaining on the carboxyl 
end could not be matched to any known structural template, but are predicted by secondary 
structure sequence analysis to be an alpha helix.  
Figure 7: Predicted Structure of Rv2633c C-terminus 
 
No model generated from this program could conserve a metal cofactor binding site or 
ligand binding site of any kind. Though each model template selected had a bound ligand, the 
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binding sites were not conserved well enough to be added to the models. This has interesting 
implications of the active site of Rv2633c, as sequence analysis as well as experimental evidence 
suggests the existence of a metal cofactor.  
The table below shows relevant statistical data about each generated structural model. 
The GMQE score (Global Model Quality Estimation) estimates the accuracy of the model built 
with the specified template, and is expressed as a number between 0 and 1, with higher numbers 
indicating a higher accuracy. The QMEAN4 score is a linear combination of the four QMEAN 
ranked structural descriptors of a model: solvation, torsion, Cβ distance dependence, and all atom 
distance dependence. The output is that of a Z-score, with a Z score of zero comparing to a high 
resolution X-ray model generated from a crystal structure [71].  
Table 2: Generated Structural Models of Rv2633c 
Template Name GMQE Score QMEAN4 
Score 
Amino Acid 
Range Covered 
Coverage 
Hypothetical protein 
NMB1532 
0.50 -5.96 1-138 0.84 
hemerythrin-like 
domain protein 
DcrH 
0.40 -4.23 4-119 0.70 
Bacteriohemerythrin 0.39 -3.74 4-117 0.69 
F-box/LRR-repeat 
protein 5 
0.45 -7.25 4-136 0.81 
 
The four probable models are shown below, along with a summary of each models’ 
details. The cartoon models show the structural features of each protein, with blue indicating the 
N-terminus and red indicating the C-terminus.  
 
 
 24 
  
Figure 8: Predicted Model from Template Protein Hypothetical protein NMB1532  
 
Figure 9: Predicted Model from Template Protein Hemerythrin-like Domain Protein DcrH  
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Figure 10:Predicted Model from Template Protein Bacteriohemerythrin from Methylococcus capsulatus 
 
Figure 11: Predicted Model from F-box/LRR-repeat protein 5 
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Model Prediction Accuracy  
A separate program, MODFold 4, was used to analyze the probability of the model 
produced [63-65]. The program ranks structural models against the known model and determines 
the probability the predicted model is correct. The Global Model Quality Score predicts the 
likelihood of an accurate model [63-65]. It is a number between 0 and 1, with scores below 0.2 
indicating relatively improperly folded models and scores above 0.4 indicating more confident 
model predictions [63-65]. Each of the four generated models are shown in cartoon figures 
colored by RasMol temperature coloring, with blue indicating regions of low position 
uncertainty and areas of red with high position uncertainty. The graphs shown predict the error in 
Angstroms of the predicted alpha carbon position by the model with the native form of the 
corresponding of the native structure. This shows regions of the predicted model that likely 
contain the most error. The green lines show positions where the protein template was not 
matched with the target sequence [63-65].   
Table 3: MODFOLD4 Model Prediction Accuracy  
Model Template Global Model 
Quality Score 
P-Value Confidence 
Rating 
Hypothetical protein 
NMB1532 
0.4461 0.00873 High 
Hemerythrin-like 
domain protein 
DcrH 
 
 
0.3650 0.02029 Medium 
Bacteriohemerythrin 
(Methylococcus 
capsulatus) 
0.3561 0.02225 Medium 
F-box/LRR-repeat 
protein 5 
0.2933 0.02933 Medium 
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The model produced from NMB1532 was ranked with a global model quality score of 
0.4461. The NMB1532 model had the highest probability of being correct, rated with the P-value 
of 0.00873.  Interestingly, NMB152 binds Mn2+, rather than diiron derivatives. While this seems 
counter intuitive due to the hemerythrin domain present in the sequence, the binding site of the 
manganese cation was not conserved in the generated model. It must also be taken into 
consideration that the sequence similarity of this protein to Rv2633c is only 18.38%.   
Out of the four models, the model produced from Hypothetical Protein NMB1532 was 
selected as the most probable model. This model also had the highest quality rating predicted by 
the SWISS-MODEL program. This model most likely shares the greatest overall structural 
homology.  
Although programs exist that can align multiple templates, this technique was not used, 
in favor of selecting the most probable model. A study on using multiple templates to improve 
quality of homology models in automated homology modeling showed that using multiple 
templates on average does little to improve the generated model [72]. Using multiple templates 
generally only improves models by extending the length of the protein model, but the selected 
model has the most protein sequence modeled out of the four analyzed.  
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Figure 12: Hypothetical protein NMB1532 Error Prediction Model  
 
Figure 13: Hypothetical protein NMB1532 Error Prediction by Amino Acid Residue 
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Figure 14: Hemerythrin-like domain protein DcrH Error Prediction Model  
 
Figure 15: Hemerythrin-like domain protein DcrH Error Prediction by Amino Acid Residue 
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Figure 16: Bacteriohemerythrin (Methylococcus capsulatus) Error Prediction Model 
 
Figure 17: Bacteriohemerythrin (Methylococcus capsulatus) Error Prediction by Amino Acid Residue 
 
 
 
 31 
  
Figure 18: F-box/LRR-repeat protein 5 Error Model 
 
Figure 19: F-box/LRR-repeat protein 5 Error Prediction by Amino Acid Residue 
 
Cofactor Binding Predictions 
Though a bound ligand was not conserved using the possible templates generated by the 
SWISSMODEL program, experimental evidence suggests the presence of a metal cofactor. The 
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program COFACTOR was used to predict the presence of cofactors, by using the generated 3D 
structures of Rv2633c and comparing them to related protein cofactor binding sites from 
resolved structures [66-68]. For this analysis, the generated models from each selected template 
were matched with ligand binding sites from related protein structures, and the accuracy of the 
binding site was accessed. The CscoreLB is the confidence score of the predicted binding site and 
is a number between 0 and 1, with 1 being the most probable model. The BS score is the 
sequence and structure similarity between the binding site of the template and the predicted 
ligand binding site of the model, with a score of greater than 1 indicating a significant match 
between the two [66-68].  
Table 4: COFACTOR Ligand Binding Prediction  
Model 
Template 
Predicted 
Ligand 
Binding Site 
Template 
CscoreLB BS Score Predicted Binding Site 
Residues 
Hemerythrin-
like domain 
protein DcrH 
FeA 
 
met-azido-DcrH-Hr 0.61 1.19 11,14,45,46,49,67,71, 
101,102,105,106,110 
 
Bacterioheme
rythrin 
(Methylococc
us 
capsulatus) 
CFO Met DcrH-Hr 
 
0.55 1.22 11,45,47,49,67,71,102, 
105,106,110 
 
Hemerythrin-
like domain 
protein DcrH 
FeO Deoxy-DcrH-Hr 0.31 1.21 11,45,49,67,71,105, 
110 
 
 
Hypothetical 
protein 
NMB1532 
MN Hypothetical 
protein NMB1532 
0.27 1.29 11,45,49,109, 
114 
 
 
The program Swiss-PdbViewer 4.1.0 was used to generate images of the protein models 
with the predicted bound cofactors. The PDB file was generated from the COFACTOR server. 
However, the models constructed are high in error, and are used as a reference only, as the model 
structures do no truly fit the structural requirements to bind the cofactors shown effectively by 
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the SWISS-MODEL program. Images were generated showing the probable location of the 
bound cofactor in several different displays. All of the four previously discussed models were 
tested against the COFACTOR program, and the three most probable ligand binding sites were 
chosen for further study. Predicted binding sites below 0.25 were not considered, as these likely 
have low homology to the true native structure of the protein.  
The highest scoring binding site similarity was generated from the Hemerythrin-like 
domain protein DcrH model, which predicted azide bound to a µ-oxo diiron bridge. The second 
most probable binding site similarity was also generated from the same predicted structural 
model, but bound with the oxidized form rather than azide. However, it most be taken into 
account that the structural model generated from DcrH was not the highest predicted similarity 
model. The third possible cofactor was a Mn2+ atom. Though given a confidence score of only 
0.27, the model the data is generated from is the highest ranked structural model of Rv2633c. 
The model generated from F-box/LRR-repeat protein 5 could not be matched to the 
corresponding ligand known to bind the target protein, showing a low chance of a similar 
binding site in Rv2633c.  
The cartoon image of the protein bound to the cofactor generated by the COFACTOR 
program is shown, followed by the model with only predicted cofactor binding residues shown.  
 
 
 
 
 
 34 
  
Figure 20: Monoazido-µ-oxo-diiron binding model of Rv2633c generated from the structural template hemerythrin-like 
domain protein DcrH 
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Figure 21: µ-oxo-diiron binding model of Rv2633c generated from the structural template hemerythrin-like domain 
protein DcrH 
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Figure 22: Predicted Mn2+ Binding site of Rv2633c from Template Sequence Hypothetical protein NMB1532 
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Figure 23: Chloro-diiron-oxo binding site predictions of Rv2633c generated with template model Bacteriohemerythrin 
(Methylococcus capsulatus) 
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Site Directed Mutagenesis Predictions 
Though the focus of this work was on the wild type protein, the extensive sequencing and 
predictive structural analysis of wild type Rv2633c showed residues whose mutation may be 
telling of protein function. Histidine residues 11, 45, and 49 are the immediate choices, as these 
residues were conserved as predicted binding sites in every significant prediction by 
COFACTOR. Histidine 105 is also a conserved binding residue in three of the four most 
probable binding site predictions. Histidine residues are also known to be the main amino acid 
associated with the µ-oxo diiron binding site of hemerythrin proteins [42]. Substitution of these 
histidine residues would render the protein unable to bind the predicted cofactor. Alanine 106 
may also serve as a useful target for mutagenesis, as it seems to play some role in shaping the 
binding pocket of the predicted cofactor. Leucine 101 may also have a similar function. Histidine 
residue or glutamate residues 126, 128, or 129 could test the possibility of the unique ‘ferritin-
like superfamily’ c terminus of this protein playing some role in its function, as ferritin-like 
proteins are known to bind diiron, or in some cases manganese, using glutamate and histidine 
residues in close proximity [70].  
Purification and Expression of Recombinant 
Various expression methods were used to determine optimum conditions for isolation of 
large amounts of protein, as well as protein with the putative diiron cofactor. Table 5 summarizes 
the purifications and expressions performed. In each case relatively high concentrations of 
recombinant protein were obtained. The recombinant protein was highly pure when analyzed 
qualitatively with SDS-PAGE. SDS-PAGE of each step in the purification also shows a 
substantial amount of recombinant protein was present in the insoluble portion of the lysate. 
Whether this is due to unfolded inclusion bodies or an inherent property of the native protein is 
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unclear. Protein concentration of each preparation was performed by a quantitative Bradford 
assay in order to compare the relative amount of protein purified from each expression.  
Figure 24: Stained SDS-PAGE of Rv2633c.  
Starting from left the wells are: Rv2633c, Rv2633c, resolubilized pellet, buffer wash volume 3, buffer wash volume 2, flow 
through 1, flow through 2, flow through 3, prestained protein ladder (MWs: 170, 130, 95, 72, 55, 43, 34, 26, 17, 10 kDa) 
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Figure 25: UV-Visible Absorbance Spectrum of Rv2633c Expression and Purification Methods 
 
Hemerythrin proteins characteristically have absorbance in the 330-350 nm range, as well 
as in the 550 nm, range when in the oxidized form, while has no characteristic absorbance when 
lacking iron cofactor or in the deoxy state (Fe( II, II)). [73]. Though the expression and 
purification methods used returned high concentrations of protein each time, the unique 
absorbance present at 330 nm that correlates to possible presence of cofactor was not 
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consistently reproduced (Figure 25). The ratio of the absorbance at 280 nm was compared with 
the absorbance at 330 nm (Table 5). This comparison was made to determine the amount of 
protein that may contain cofactor to the overall protein purified. By comparing this ratio from 
each preparation of Rv2633c, it could be determined which purification and expression method 
was most successful in producing protein with hemerythrin-like absorbance. For a baseline, 700 
nm absorbance was chosen to remove any light scattering that may contribute to shorter 
wavelength measurements. 
A lower ratio of 280 nm absorbance to 330 nm absorbance would be ideal, as this likely 
means more of the cofactor is present in the protein. The 700 nm baseline showed that the 
absorbance measurements are consistent enough to allow for comparison. The absorbance at 330 
nm was compared to the concentration in order to determine if the cofactor absorbance spectrum 
could be correlated to the amount of protein. The results show that the absorbance at 330 nm, 
and likely the cofactor bound to Rv2633c, is highly variant in each expression and purification, 
even when conditions were repeated.  
The absorbance at 330 nm depends on variables more complex than expression 
temperature, molarity of IPTG during induction and purification technique. However, the data 
shows that purification with imidazole as the elution agent contributed to destabilizing cofactor 
binding. Iron atoms within a hemerythrin domain are bound by interactions with histidine 
residues, so it is logical that addition of high concentrations of imidazole could destabilize a 
bound cofactor. Acidic conditions used for purification also destabilized the protein, this 
preparation had the highest 280nm/330nm ratio (Table 5). Hemerythrin-like proteins have also 
been shown experimentally to destabilize in acidic conditions [74]. 
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Table 5: Protein Concentrations, Measured Absorbance, and Ratios 
Prep  280 nm 350 nm 700 nm Concentration 
mg/ml  
280/35
0 
330/ 
concentratio
n 
25 mM Imidazole 
Expressed at Room 
Temperature 
Overnight 
1.25 0.84 0.13 1.129  1.48 0.75 
25 mM Imidazole 
Expressed at Room 
Temperature 
Overnight with 1 
mM Iron during 
growth 
0.70 0.19 0.0059 0.844  3.65 0.23 
25 mM Imidazole 
Expressed at Room 
Temperature 
Overnight 
0.24 0.12 0.055 0.0280  1.94 4.46 
25 mM Imidazole 
Expressed at 37ºC 
for 3 hours 
0.51 0.16 0.050 3.973  3.04 0.051 
Acid, MES pH 5, 
followed by EDTA 
25 mM 01.03.16 
0.65 0.17 0.049 0.7575  3.94 0.22 
25 mM EDTA 
Expressed at Room 
Temperature 
Overnight 
1.29 0.44 0.072 2.313  2.92 0.19 
 
Response to Relevant Conditions of the Macrophage 
Oxygen Binding 
Hemerythrin like proteins often have the ability to reversibly bind O2 with a noticeable 
change in UV-visible absorbance when bound and unbound [42]. If Rv2633c bound O2 
reversibly, anaerobic conditions may have show spectral shifts. Nitrogen purging of the sample 
in an anaerobic quartz cuvette for 40 minutes showed no noticeable change in the UV-visible 
absorbance spectrum of Rv2633c. If the 330 nm peak was caused by the presence of reversibly 
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bound dioxygen there would likely have been some change after the removal of oxygen, as 40 
minutes should be sufficient to remove almost all traces of dioxygen from the protein sample.  
When SNAP (S-Nitroso-N-acetylpenicillamine) was added to the protein samples to 
release nitric oxide, no change in the UV-visible absorbance spectrum was observed. Changes in 
absorbance that did occur were due to the baseline absorbance of SNAP reagent. As dioxygen 
binding proteins generally bind nitric oxide as well, this result also suggests Rv2633c does not 
reversibly bind dioxygen.  
Hydrogen Peroxide Addition and Dialysis 
Hydrogen Peroxide was added in order to study the protein’s response to reactive oxygen 
species, which are present in the macrophage lysosome. The amount of hydrogen peroxide added 
was far above conditions that could be found in a biological system, at approximately 0.4 M. 
However, the results have interesting implications for the cofactor within Rv2633c. H2O2 causes 
a large, reversible UV-visible spectrum shift, as well as changes in the protein color clearly 
visible by eye. Concentrated Rv2633c containing the cofactor has a pink to brown color. The 
spectrum shifts to peak absorbance at approximately 550 nm (Figure 26), which is consistent 
with the absorbance spectrum of a hemerythrin protein in the oxidized form [73]. Controls with 
BSA and the same concentration of H2O2 show some spectral shifts that are barely present, and 
are likely associated with the presence of H2O2.  
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Figure 26: Hydrogen Peroxide Addition Causes Increase in Absorbance at 330 nm and 550 nm 
 
  
Upon dialysis, the Rv2633c almost completely regains its original spectrum and color, 
including the 330 nm peak. This suggests that the changes caused by H2O2 are happening to the 
cofactor, rather than just the result of degradation of the protein.  
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Figure 27: Overnight Dialysis of Hydrogen Peroxide Shows Spectral Shifts are Reversible 
 
Measurements of the absorbance spectrum on the seconds scale shows interesting 
spectral shifts that may be telling of the state of the cofactor. The absorbance at 330 nm rapidly 
increases upon addition of hydrogen peroxide and then slows after about a minute. The peak at 
550 nm begins to appear immediately after the hydrogen peroxide addition but then increases 
rapidly after about 2 minutes.  
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Figure 28: Change in 330 nm Absorbance Increases Rapidly upon Hydrogen Peroxide Addition  
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Figure 29: Change in 550 nm Absorbance Increases Rapidly within 2-4 min after Hydrogen Peroxide Addition   
 
Upon addition of the same concentration of tert-butyl hydrogen peroxide, there is no 
change in absorbance spectrum. This suggests the reaction occurring depends on the reactive 
molecule from hydrogen peroxide must have access to the binding site of the protein in order to 
occur. Tert-butyl hydrogen peroxide has the same properties as hydrogen peroxide, but with a 
bulky carbon side group. This is further evidence to suggest the presence of a metal cofactor.  
Reducing Agent Addition  
The reducing agents TCEP or glutathione were added to Rv2633c to study the effects of 
reducing equivalents on the protein. No changes in UV-visible spectra were observed up to 1 
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mM.  However, at 10 mM, light scattering increased within a few minutes. This was especially 
noticeable when TCEP was added. The observed light scattering is likely due to polymerization 
or formation of oligomers of Rv2633c. Cloudiness was visibly present in the protein. This was 
more significant with the addition of TCEP, where visual inspection of the solution showed what 
appeared to be precipitates. 
Figure 30: Addition of 10 mM Glutathione causes Light Scattering that cannot be Reversed by Dialysis 
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Figure 31: Addition of 10 mM TCEP causes Light Scattering and Aggregation that cannot be Reversed by Dialysis 
 
After overnight dialysis in 50 mM tris pH 8 the protein still showed significant light 
scattering, but the cofactor appeared to no longer be present in the protein. Though hard to tell by 
UV-Visible absorbance spectrum due to the extreme light scattering, the protein color changed 
from light pink to almost completely clear. The reducing agents may have destabilized or 
unfolded the protein in some way, causing loss of cofactor. Due to the high concentrations 
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needed for noticeable change, the results may also have been caused by denaturation of the 
protein.  
CONCLUSIONS 
Sequence Analysis and Structural Modeling Predictions 
Sequence analysis of Rv2633c shows very low homology with non-mycobacterium 
species. And within the mycobacteria, the presence of a protein sequence highly similar to 
Rv2633c correlates within the pathogenic strains of mycobacterium. Only one nonpathogenic 
strain of mycobacterium, Indicus pranii, is selected by NCBI Blast as a significant alignment, 
and it is predicted to be the furthest related mycobacterium species. The C terminal sequence 
also seems to be even more predictive of pathogenic species of mycobacteria.  
Analysis of the predicted structural homology of Rv2633c proves difficult, due to the low 
sequence homology with available structural templates. However, there were several 
observations that could be drawn from the generated structural models. Each model produced 
had a similar overall structure of two sets of approximately parallel alpha helices arranged into a 
tunnel with a hollow center. The center of the helices is partially blocked by a fifth alpha helix 
on the carboxyl end. This general structure coincides with the known structure of hemerythrin 
and hemerythrin-like proteins. This evidence strongly suggests this as a good model for the 
general structure of Rv2633c.  
Though the structural prediction of manganese binding Hypothetical protein NMB1532 
was valued as the closest to the native structure of Rv2633c, this is not likely enough information 
to rule out the presence of the cofactor to be a diiron µ-oxo bridge. Though the NMB1532 model 
was rated the highest predicted model in overall structure, the predictions that include the 
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binding site of Rv2633c are actually rated lower in probability compared to models off of protein 
structures known to bind diiron. The length of sequence coverage is highly factored into 
probability calculations of predicted models, yet the extra amino acid residues that are included 
when using the NMB1532 model do not coincide with any predicted binding site.  
Purification and Expression  
Expressing large quantities of pure recombinant protein was fairly simple, and different 
expression and purification methods produced amounts between 2 and 3 mg/ml. The largest yield 
obtained was 59.8 mg from a 4 liter growth of cells. However, due to the unstable nature of the 
predicted cofactor binding, expression and purification of a stable, cofactor containing form of 
Rv2633c proved difficult. Purification using imidazole was unpredictable in terms of cofactor 
yield. All but one preparation resulted in no spectrally visible 330 nm peak. Purification with the 
EDTA strategy showed consistency in the presence of the cofactor, though at a lower apparent 
level. The 330 nm peak predicted to correspond to diiron cofactor was visually present, and the 
protein was reactive to hydrogen peroxide. However, when compared to the successful 
purification of cofactor containing protein using imidazole the peak is much less intense. Various 
expression and purification methods showed that the cofactor is easily destabilized by 
environmental conditions. Purification of histidine tagged Rv2633c with EDTA to strip the 
cobalt and protein off the column served as the most consistent method for purification, though 
the metal chelating properties likely destabilized a portion of the protein. In future studies, it may 
be more useful to clone Rv2633c into a new vector containing a different purification tag, such 
as a GST tag.  
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In vitro Macrophage Conditions  
Based on experiments where oxygen levels were removed, or SNAP was used to generate 
nitric oxide, it is unlikely that Rv2633c reversibly binds dioxygen. However, whether Rv2633c is 
unable to bind O2, or is bound too tightly to release under these conditions, cannot be 
determined. Neither of these methods commonly used to test for the binding of dioxygen showed 
any spectral changes. While it is possible that dioxygen binding occurs and is just not shown by 
changes in UV-visible absorbance, this is likely not the case as hemerythrin domains in varying 
protein and organisms show changes in absorbance corresponding to the presence and absence of 
dioxygen [42].  
Rv2633c responded poorly to reducing conditions, and there was noticeable aggregation 
of protein that could not be reversed by dialysis. Prolonged exposure to reducing agents also 
seemed to strip the protein of the cofactor, as the 330 nm absorbance peak diminishes almost 
completely.  
The highly oxidative environment generated by high concentrations of hydrogen peroxide 
caused considerable changes in Rv2633c. There appears to be two reactions occurring. The peak 
absorbance at 330 nm increases rapidly immediately upon addition of hydrogen peroxide, with 
small growth of a 550 nm absorbance peak. At approximately four minutes after hydrogen 
peroxide addition there is a rapid growth in the 550 nm peak, accompanied by the visual color 
change from light pink to purple. This may be due to changes in oxidation state of the two iron 
atoms predicted to be present in the protein center, as this reaction is almost completely 
reversible upon dialysis. The addition of the same concentration of tert-butyl hydrogen peroxide 
does not cause any noticeable shift in absorbance, therefore the hydrogen peroxide group likely 
must be able to enter the protein center in order to cause oxidation effects.   
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DISCUSSION  
Tuberculosis infection continues to be a serious health risk around the world, especially 
for individuals in developing countries and those who are immunocompromised. With the 
continuing prevalence of Mtb antibiotic resistance, research into the virulence and persistence of 
Mtb is greatly needed. Rv2633c is a promising candidate for further investigation. The presence 
of this gene in mycobacteria strongly correlates with pathogenic species of mycobacteria. 
Rv2633c has been shown experimentally to be upregulated during the initial stages of virulence.  
Rv2633c shows reversible reactivity with hydrogen peroxide. Based on the known 
literature of hemerythrin oxidation states, I predict the spectral shifts caused by hydrogen 
peroxide are caused by the µ-oxo diiron being oxidized from an Fe(II, II) or possibly (Fe II, III) 
state to a fully oxidized Fe (III, III) form. Oxidized hemerythrin has a very similar absorbance 
spectrum: no noticeable absorbance spectrum in the deoxy and diiron free form, a 330 nm peak 
observed in the met-form, and a 330 nm and a noticeable peak at around 550 nm only in the 
oxidized state [75].  
My speculative prediction for the function of Rv2633c is iron sensing. Sequence analysis 
of Rv2633c predicts two different domains involved in the binding of iron: hemerythrin and 
ferritin-like domain. Experiments performed on the recombinant protein do not show any 
noticeable reversible dioxygen binding so the hemerythrin-like domain of Rv2633c is most likely 
not used to bind dioxygen. Based on experiments performed in this work, Rv2633c is likely not 
involved in iron storage. Mycobacteria have known proteins highly successful in iron 
sequestration and storage. The predicted diiron cofactor also experimentally seems to be bound 
unstably, so continual iron binding required for storage seems unlikely. Structural predictions are 
also unable to fully conserve cofactor binding sites. FBox and Leucine-Rich repeat protein 
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(FBXL5), one of the templates used for previous homology models of Rv2633c, has 20% 
sequence identity with Rv2633c, and has been characterized as an iron homeostasis protein [76]. 
FBXL5 senses cellular iron levels by binding µ-oxo diiron with a hemerythrin-like domain and 
destabilizing when not bound to iron [76]. Preliminary data from Dr. Kyle Rohde shows Mtb 
without the Rv2633c gene seem to grow better when compared to the wild type. Perhaps 
Rv2633c plays a role in sensing unfavorable conditions for growth.  
Future studies of Rv2633c are needed to fully understand the part it plays in the virulence 
and survival of Mtb in the human macrophage. Determination of the true metal content of 
Rv2633c by ICP-MS would help elucidate the chemistry occurring when reacting in oxidizing 
environments. Further testing to determine if Rv2633c exists in its native state as a monomer or 
an oligomer would also give insight into its function. Various experimental conditions showed 
evidence of oligomerization by Rv2633c. SDS-PAGE of highly purified recombinant protein 
show recurrent faint bands at positions of high molecular weights. The addition of reducing 
agents caused fast and varying aggregation, which could possibly be due to the propensity to 
form oligomers. Hemerythrin proteins are known to form oligomers, and ferritin-like proteins are 
also shown to form extremely large oligomers, such as dodecamers, in order to function properly 
[42, 77]. A crystal structure is the next logical step for truly understanding the structure of 
Rv2633c.  
Continued research into the function of Rv2633c in Mtb virulence will likely yield a 
greater understanding of the remarkable resilience of Mtb within the human macrophage. The 
high expression of this protein during uptake into the macrophage and acidification of the 
lysosome could prove a promising drug target in the fight against tuberculosis infection.  
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